Cohesin is a protein complex that is essential for chromosome segregation in dividing cells. Recent evidence suggests that it also plays an important role in 3D genome architecture, which folds like an origami and regulates essential cellular processes that include gene expression, DNA replication and DNA repair. Cohesin mutations have been identified in some types of cancer and in rare diseases referred to as cohesinopathies.
In a paper published in Cell Reports, a group of researchers describe new functions of cohesin in mouse embryonic stem cells that might help understand and address the causes of these disorders.
C0hesin has two variants, containing either SA1 or SA2. While the gene that encodes SA2 shows high mutation rates in certain types of cancer, like bladder cancer, acute myeloid leukaemia or Ewing sarcoma, mutation rates of SA1 are much lower.
In 2018, a study revealed the distinct roles of each variant in human epithelial cells. Now, the researchers have taken a further step to determine what role each variant plays in the peculiar genome architecture of embryonic stem cells, that is, the pluripotent cells that can produce all the cell types of the adult organism.
Studying mouse embryonic stem cells - similar to human embryonic stem cells -, the team publishing in Cell Reports how cohesin-SA1 contributes to differentiate the distinct regions (TADs) in which the genome is organised, cohesin-SA2 helps to regulate the expression of genes that have a role in keeping the pluripotency of stem cells - pluripotency is the property that enables stem cells to originate all the cell types that make up the adult organism.
"Confirming that what we observed in human cells also occurs in such different cell types as mouse embryonic stem cells was really important to us," says the corresponding author of the research paper. Moreover, the study provides evidence for a novel role of cohesin in the structure of embryonic stem cells. "We have shown for the first time how cohesin contributes to the 3D organization of Polycomb domains," the author adds.
Polycomb domains are 3D genome structures that exist only in embryonic stem cells, as if it were an extra folding in the origami of its genome that is missing in the differentiated tissue cells. These regions, characterised by the presence of Polycomb complexes, are essential to prevent the expression of the genes encoding proteins with specific functions in embryonic development. Polycomb complexes, then, are involved in the repression of genes that otherwise would help initiate cell differentiation. The study published in Cell Reports revealed that cohesin-SA2 is present in these regions too, where it retains one of the proteins in the Polycomb complex. "When the levels of cohesin-SA2 in cells decrease, Polycomb protein levels in relevant chromatin domains decrease as well," says the first co-author and co-corresponding author of the study. "Consequently, chromosome folding loosens and the expression of tissue-specific genes is not properly silenced. Stem cells are no longer pluripotent and cannot work properly."
In addition, Polycomb domains in distant chromosome regions, even in different chromosomes, interact with each other and in so doing facilitate gene repression. In retaining Polycomb proteins, cohesin-SA2 promotes such interactions. "We did not expect cohesin-SA1 to have just the opposite function, preventing those contacts," says the first co-author of the research paper.
Further study is required to understand the link between cohesin and Polycomb complexes in differentiated cells and its probable contribution to the emergence of cancer cells. "We believe that these lines of research will help us understand the role of cohesin mutations in cancer development and cohesinopathies, like Cornelia de Lange syndrome," the author concludes.
https://www.cnio.es/en/news/publications/cnio-researchers-describe-new-functions-of-protein-that-plays-key-role-in-some-tumours-and-rare-diseases/
https://www.cell.com/cell-reports/fulltext/S2211-1247(19)30707-7
New functions of stem cell protein involved in some tumors and rare diseases
- 1,424 views
- Added
Edited
Latest News
Brain hormone regulate both…
By newseditor
Posted 17 Mar
Blocking long non-coding RN…
By newseditor
Posted 17 Mar
Artificial intelligence and…
By newseditor
Posted 17 Mar
Blood-brain barrier protein…
By newseditor
Posted 17 Mar
Preventing heart attacks an…
By newseditor
Posted 17 Mar
Other Top Stories
An implant for nerve stimulation to treat stroke
Read more
Body parts respond to day and night independently from brain
Read more
New imaging tool for diagnosing heart disease
Read more
Toxic fatty acid buildup removal by astrocytes to protect neurons
Read more
Three gene mutations together cause deadly human heart disease
Read more
Protocols
Integration of Kupffer cell…
By newseditor
Posted 18 Mar
A mouse DRG genetic toolkit…
By newseditor
Posted 17 Mar
An optogenetic method for t…
By newseditor
Posted 13 Mar
Profiling native pulmonary…
By newseditor
Posted 08 Mar
Neuromuscular organoids mod…
By newseditor
Posted 06 Mar
Publications
Synaptopathy: presynaptic c…
By newseditor
Posted 18 Mar
Allergic Rhinitis
By newseditor
Posted 18 Mar
ALK upregulates POSTN and W…
By newseditor
Posted 18 Mar
PRODH safeguards human naiv…
By newseditor
Posted 18 Mar
Secretin-dependent signals…
By newseditor
Posted 17 Mar
Presentations
Hydrogels in Drug Delivery
By newseditor
Posted 12 Apr
Lipids
By newseditor
Posted 31 Dec
Cell biology of carbohydrat…
By newseditor
Posted 29 Nov
RNA interference (RNAi)
By newseditor
Posted 23 Oct
RNA structure and functions
By newseditor
Posted 19 Oct
Posters
A chemical biology/modular…
By newseditor
Posted 22 Aug
Single-molecule covalent ma…
By newseditor
Posted 04 Jul
ASCO-2020-HEALTH SERVICES R…
By newseditor
Posted 23 Mar
ASCO-2020-HEAD AND NECK CANCER
By newseditor
Posted 23 Mar
ASCO-2020-GENITOURINARY CAN…
By newseditor
Posted 23 Mar